StockData
Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO) stock

INONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$1.69+0.06 (+3.68%)

Close on Nov 18, 2026Market cap $174.74MP/E –Yield –

Inovio Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Inovio Pharmaceuticals's market cap was $121.45M on Nov 11, 2026, against $110.36M a year earlier. Over the last 5 years it ranged from $47.24M to $1.05B, with a median of $124.88M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$121.45M+30.3%
2025Dec 31, 2025$93.21M+95.5%
2024Dec 31, 2024$47.68M-65.3%
2023Dec 29, 2023$137.57M-64.7%
2022Dec 30, 2022$389.21M-62.9%
2021Dec 31, 2021$1.05B-29.2%
2020Dec 31, 2020$1.48B+353.6%
2019Dec 31, 2019$326.87M-13.5%
2018Dec 31, 2018$377.90M+1.3%
2017Dec 29, 2017$372.93M-27.4%
2016Dec 30, 2016$513.35M+5.8%
2015Dec 31, 2015$485.05M-12.6%
2014Dec 31, 2014$555.00M-7.8%
2013Dec 31, 2013$602.10M+800.8%
2012Dec 31, 2012$66.84M-0.6%
2011Jul 29, 2011$67.22M–

More Inovio Pharmaceuticals figures

See a number that looks wrong?